The curcumin analog EF24 is a novel senolytic agent

Wen Li, Yonghan He, Rongping Zhang, Guangrong Zheng, Daohong Zhou

Producción científica: Articlerevisión exhaustiva

95 Citas (Scopus)


Cellular senescence is a hallmark of aging because senescent cells (SCs) accumulate with aging and play a causative role in age-related diseases. Selectively eliminating SCs has been emerging as a new strategy for treating age-related diseases and extending healthspan. Curcumin and its analogs have some anti-aging activities. However, the mechanisms of their action have not been fully elucidated. In the present study, we investigated whether various curcumin analogs can function as a senolytic agent. The results from our studies show that among these curcumin analogs EF24 is the most potent and broad-spectrum senolytic agent. Mechanistically, EF24 selectively kills SCs by inducing SC apoptosis in a reactive oxygen species (ROS) production independent manner but associated with an increase in the proteasome degradation of the Bcl-2 anti-apoptotic protein family proteins known to play an important role in protecting SCs from apoptosis. In addition, EF24 can synergistically kill SCs with ABT-263, a Bcl-2 and Bcl-xl inhibitor and a known senolytic agent. These findings provide new insights into the mechanisms by which curcumin analogs function as an anti-aging agent and suggest that the curcumin analog EF24 has the potential to be used as a novel senolytic agent for the treatment of age-related diseases.

Idioma originalEnglish (US)
Páginas (desde-hasta)771-782
Número de páginas12
EstadoPublished - ene 1 2019
Publicado de forma externa

ASJC Scopus subject areas

  • Aging
  • Cell Biology


Profundice en los temas de investigación de 'The curcumin analog EF24 is a novel senolytic agent'. En conjunto forman una huella única.

Citar esto